<SEC-DOCUMENT>0001193805-22-001344-index.html : 20221011 <SEC-HEADER>0001193805-22-001344.hdr.sgml : 20221011 <ACCEPTANCE-DATETIME>20221011083038 ACCESSION NUMBER: 0001193805-22-001344 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20221010 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221011 DATE AS OF CHANGE: 20221011 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNIC, INC. CENTRAL INDEX KEY: 0001280776 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562358443 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36201 FILM NUMBER: 221302452 BUSINESS ADDRESS: STREET 1: 1200 AVENUE OF THE AMERICAS STREET 2: SUITE 200 CITY: NEW YORK STATE: X1 ZIP: 10036 BUSINESS PHONE: (332) 255-9818 MAIL ADDRESS: STREET 1: 1200 AVENUE OF THE AMERICAS STREET 2: SUITE 200 CITY: NEW YORK STATE: X1 ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: VITAL THERAPIES INC DATE OF NAME CHANGE: 20040219 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>e621975_8k-immunic.htm <TEXT> Document 1 - file: e621975_8k-immunic.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>2 <FILENAME>e621975_ex4-1.htm <TEXT> Document 2 - file: e621975_ex4-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>3 <FILENAME>e621975_ex10-1.htm <TEXT> Document 3 - file: e621975_ex10-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>e621975_ex99-1.htm <TEXT> Document 4 - file: e621975_ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>5 <FILENAME>imux-20221010.xsd <DESCRIPTION>XBRL SCHEMA FILE <TEXT> Document 5 - file: imux-20221010.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>6 <FILENAME>imux-20221010_lab.xml <DESCRIPTION>XBRL LABEL FILE <TEXT> Document 6 - file: imux-20221010_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>7 <FILENAME>imux-20221010_pre.xml <DESCRIPTION>XBRL PRESENTATION FILE <TEXT> Document 7 - file: imux-20221010_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>8 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 8 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>e621975_8k-immunic_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: e621975_8k-immunic_htm.html
Document 9 - RAW XML: e621975_8k-immunic_htm.xml
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>10 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>12 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>13 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: FilingSummary.html
Document 13 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>15 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 15 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>16 <FILENAME>0001193805-22-001344-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: 0001193805-22-001344-xbrl.zip
</DOCUMENT> </SEC-DOCUMENT>